Natural anti-CCR5 antibodies in HIV-infection and -exposure
Author Information
Author(s): Lopalco Lucia, Guido Poli, Luigi Buonaguro
Primary Institution: San Raffaele Scientific Institute, Milan, Italy
Hypothesis
Natural anti-CCR5 antibodies may play a role in preventing HIV infection and could be exploited for therapy and prevention.
Conclusion
Natural anti-CCR5 antibodies can effectively block HIV infection and may provide protection in HIV-exposed individuals.
Supporting Evidence
- Natural anti-CCR5 antibodies can block HIV effectively and durably.
- These antibodies have been found in both HIV-positive and HIV-exposed seronegative individuals.
- Anti-CCR5 antibodies were isolated from various mucosal secretions, indicating a broad protective role.
Takeaway
Some people have special antibodies that can stop HIV from making them sick, and scientists think these could help protect others too.
Methodology
The study involved isolating anti-CCR5 antibodies from serum and mucosal secretions of HIV-exposed individuals and testing their ability to block HIV infection.
Potential Biases
Potential biases may arise from the selection of participants and the methods used to isolate antibodies.
Limitations
The study may not account for all variables affecting antibody presence and effectiveness in different populations.
Participant Demographics
Participants included HIV-positive individuals, HIV-exposed seronegative individuals, and long-term non-progressors.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website